NEW YORK PAIN CONSULTANTS LLC
NPI 1225549827
Pathology - Clinical Laboratory Director, Non-physician in Columbia, MD

NPI Status: Active since October 23, 2017

Contact Information

9151 RUMSEY RD STE 150A
COLUMBIA, MD
ZIP 21045
Phone: (410) 910-2949

Get Directions Write a Review

  • Organization
  • Pathology
  • Clinical Laboratory Director, Non-physic...
  • CLIA Number: 21D2130305
  • CLIA Cert. Type: Physician Office
  • CLIA Exp. Date: 06-25-2026

About NEW YORK PAIN CONSULTANTS LLC

This page provides the complete NPI Profile along with additional information for New York Pain Consultants Llc, a provider established in Columbia, Maryland operating as a Pathology, focusing in clinical laboratory director, non-physician . The healthcare provider is registered in the NPI registry with number 1225549827 assigned on October 2017. The practitioner's primary taxonomy code is 247ZC0005X. The provider is registered as an organization and their NPI record was last updated one year ago. New York Pain Consultants Llc operates as a Multi-Specialty Group with one or more individual practitioners, who practice different areas of specialization. The authorized official of this NPI record is Nicole Finkle (Rcm Sr. Director)

NPI
1225549827
Provider Name
NEW YORK PAIN CONSULTANTS LLC
Entity Type
Organization
Location Address
9151 RUMSEY RD STE 150A COLUMBIA, MD 21045
Location Phone
(410) 910-2949
Mailing Address
4960 SW 72ND AVE STE 405 MIAMI, FL 33155
Mailing Phone
(469) 458-9222
Mailing Fax
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
10-23-2017
Last Update Date
09-16-2025
Code Navigator

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Pathology Clinical Laboratory Director, Non-physician

Taxonomy Code
247ZC0005X
Type
Technologists, Technicians & Other Technical Service Providers
Taxonomy Description
An individual who is state-licensed as a clinical laboratory director and meets the qualifications in the Clinical Laboratory Improvement Amendments of 1988 for non-physicians (non-MD/DO) as defined in the CFR 42 Part 493.1405.

Group Taxonomy 193200000X MULTI-SPECIALTY GROUP

This provider is a business group of one or more individual practitioners, who practice with different areas of specialization.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

NICOLE FINKLE

Authorized Official Title
RCM SR. DIRECTOR
Authorized Official Phone
(719) 243-9490

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test is a detailed examination that can identify specific drugs in your system, even closely related ones. Techniques like GC/MS and LC/MS are used for high precision. This helps ensure accurate results for your safety and health.

This service was performed 440 times for 334 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test is a detailed analysis used to identify specific drugs in your system. It uses advanced techniques, such as gc/ms and lc/ms, to detect and distinguish between different drugs, even those with similar structures.

This service was performed 1,455 times for 754 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. Advanced methods like GC/MS (Gas Chromatography/Mass Spectrometry) and LC/MS (Liquid Chromatography/Mass Spectrometry) are used. These can distinguish between similar drugs, providing precise results.

This service was performed 68 times for 56 patients

Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms

A definitive drug test identifies specific drugs in your system. It uses advanced methods like gc/ms and lc/ms, which can distinguish between different types of drugs but not necessarily their 3D forms. This test offers detailed results to support your healthcare decisions.

This service was performed 685 times for 669 patients

Testing for presence of drug, by chemistry analyzers

Chemistry analyzers are used to detect the presence of drugs in your system. This test involves taking a small sample of your blood or urine. The sample is then analyzed for specific substances. The results help in understanding your health condition better.

This service was performed 1,289 times for 987 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
21D2130305
Facility Type
Physician Office
Certificate Effective Date
June 26, 2024
Certificate Expiration Date
June 25, 2026
Laboratory Director
DR. SALVADOR F. SENA
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to New York Pain Consultants Llc on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for NEW YORK PAIN CONSULTANTS LLC

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1225549827, we treat the final digit (7) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 63. The final step is to find the difference between that total and the next multiple of ten (70 - 63 = 7).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
2
Unchanged
Pos 3
2
Doubled → 4
Pos 4
5
Unchanged
Pos 5
5
Doubled → 10 → 1 + 0
Pos 6
4
Unchanged
Pos 7
9
Doubled → 18 → 1 + 8
Pos 8
8
Unchanged
Pos 9
2
Doubled → 4
Check
7
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 2 → 4 5 → 10 → 1 9 → 18 → 9 2 → 4

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 2 + 4 + 5 + 1 + 0 + 4 + 1 + 8 + 8 + 4 + 24 = 63

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 63 is 70. The difference is the calculated check digit.

70 - 63 = 7
This NPI is valid
The calculated check digit is 7, which matches the last digit of 1225549827.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1225549827, enumerated as an "organization" on October 23, 2017.

The provider is located at 9151 RUMSEY RD STE 150A COLUMBIA, MD 21045 and the phone number is (410) 910-2949.

Pathology with taxonomy code 247ZC0005X and a focus in Clinical Laboratory Director, Non-physician.